Internal Medicine Doctors in Charleston, SC Accepting Medicare

770 Internal Medicine doctors found. Showing 41 - 60

Dr. Alexander Wafic Baradei, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 169 Ashley Avenue Room 202 Main Hospital Msc333, Charleston, SC 29425 Phone: 843-791-0192

Robert Sean Ross Tyler, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 169 Ashley Ave Rm 202, Charleston, SC 29425 Phone: 843-792-5006

Dr. Anna Catherine Jameson, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-4074

Dr. Vincent Gregory Bolus, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 169 Ashley Ave Room 202 Main Hospital Msc333, Charleston, SC 29425 Phone: 843-792-1414

Zipporah Krishnasami, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414

John D Sanders, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 9275c Medical Plaza Dr, Ste C, Charleston, SC 29406 Phone: 843-797-5667    Fax: 843-569-2215

Timothy Wells, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 109 Bee St, Charleston, SC 29401 Phone: 843-577-5011

Dr. Phillip David Warr, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414

Maria F Lopes-virella, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414

Kathryn Paige Anderson, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414

Dr. Brett Matthew Tomashitis, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 169 Ashley Ave Rm 202, Charleston, SC 29425 Phone: 843-792-5386

Andres Felipe Ospina, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 169 Ashley Avenue, Rm 202, Main Hospital, Charleston, SC 29425 Phone: 843-792-5386

Dr. Lawrence Paul-anthony Debellis, DO, MS Internal Medicine Medicare: Medicare Enrolled Practice Location: 96 Jonathan Lucas St Ste 822, Charleston, SC 29425 Phone: 843-792-2529    Fax: 843-792-4114

John E Franklin, MD Internal Medicine - Hospice and Palliative Medicine Medicare: Medicare Enrolled Practice Location: 109 Bee St, 11g, Charleston, SC 29401 Phone: 843-789-7057

Robert Neal Axon, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 109 Bee St, Charleston, SC 29401 Phone: 843-789-7833

Holly C Mitchell, MD Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414

Joseph R Cantey, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414

Michael L Craig, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414

Rachana Krishna, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414

Dr. Ashley Teale Britell, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414

News Archive

Fetal genomic sequencing could enhance detection rate of genetic findings, study shows

In a study to be presented Thursday, Jan. 26, in the oral plenary session at 8 a.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, researchers with the Columbia University Medical Center in New York found that, in preliminary data, fetal genomic (whole exome) sequencing (WES) as a diagnostic test for women with pregnancies complicated by major fetal congenital anomalies increased the detection rate of genetic findings by between 10 to 30 percent.

Palatin announces private placement of common stock and warrants

Palatin Technologies, Inc. today announced that it has entered into a definitive securities agreement and priced a private placement of 3,873,000 shares of its common stock, Series A warrants to purchase 31,988,151 shares of its common stock, and Series B warrants to purchase 35,488,380 shares of its common stock.

Isis Pharmaceuticals begins ISIS-APOCIIIRx Phase 3 study in FCS patients

Isis Pharmaceuticals, Inc. announced the initiation of a Phase 3 study evaluating ISIS-APOCIIIRx in patients with familial chylomicronemia syndrome (FCS). FCS is a rare orphan disease, characterized by extremely high triglyceride levels, that affects an estimated 3,000 to 5,000 patients worldwide.

Study examines bullying, recent alcohol use and heavy drinking episodes among school students

A new study out of the University of Cincinnati finds that both school bullies and their victims are likely to abuse alcohol after a bullying episode. Keith King, a University of Cincinnati professor of health promotion, along with Rebecca Vidourek, a UC assistant professor of health promotion, will present early findings of a new study on Oct. 29, at the 140th Annual Meeting of the American Public Health Association in San Francisco.

FDA awards supplemental approval to support efficacy of ACTEMRA in treating RA

Genentech, Inc., a member of the Roche Group, today announced that the United States Food and Drug Administration has extended the ACTEMRA (tocilizumab, RoACTEMRA in the European Union) label to include inhibition and slowing of structural joint damage, improvement of physical function, and achievement of major clinical response in adult patients with moderately to severely active rheumatoid arthritis, when given in combination with methotrexate.

Read more Medical News

› Verified 6 days ago

• 1
• 2
• 3(current)
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• »